|
1
|
Rudolph E, Dyckhoff G, Becher H, Dietz A
and Ramroth H: Effects of tumour stage, comorbidity and therapy on
survival of laryngeal cancer patients: a systematic review and a
meta-analysis. Eur Arch Otorhinolaryngol. 268:165–179. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cosetti M, Yu GP and Schantz SP: Five-year
survival rates and time trends of laryngeal cancer in the US
population. Arch Otolaryngol Head Neck Surg. 134:370–379.
2008.PubMed/NCBI
|
|
3
|
Petrakos I, Kontzoglou K, Nikolopoulos TP,
Papadopoulos O and Kostakis A: Glottic and supraglottic laryngeal
cancer: epidemiology, treatment patterns and survival in 164
patients. J BUON. 17:700–705. 2012.PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar
|
|
5
|
Ferretti E, De Smaele E, Po A, et al:
MicroRNA profiling in human medulloblastoma. Int J Cancer.
124:568–577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khoshnaw SM, Green AR, Powe DG and Ellis
IO: MicroRNA involvement in the pathogenesis and management of
breast cancer. J Clin Pathol. 62:422–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Raponi M, Dossey L, Jatkoe T, et al:
MicroRNA classifiers for predicting prognosis of squamous cell lung
cancer. Cancer Res. 69:5776–5783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akao Y, Nakagawa Y and Naoe T: MicroRNAs
143 and 145 are possible common onco-microRNAs in human cancers.
Oncol Rep. 16:845–850. 2006.PubMed/NCBI
|
|
9
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Michael MZ, O’ Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
11
|
Gentleman RC, Carey VJ, Bates DM, et al:
Bioconductor: open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Papadopoulos GL, Reczko M, Simossis VA,
Sethupathy P and Hatzigeorgiou AG: The database of experimentally
supported targets: a functional update of TarBase. Nucleic Acids
Res. 37:D155–D158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papadopoulos GL, Alexiou P, Maragkakis M,
Reczko M and Hatzigeorgiou AG: DIANA-mirPath: integrating human and
mouse microRNAs in pathways. Bioinformatics. 25:1991–1993. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Newman JC and Weiner AM: L2L: a simple
tool for discovering the hidden significance in microarray
expression data. Genome Biol. 6:R812005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thompson JD, Higgins DG and Gibson TJ:
CLUSTAL W: improving the sensitivity of progressive multiple
sequence alignment through sequence weighting, position-specific
gap penalties and weight matrix choice. Nucleic Acids Res.
22:4673–4680. 1994. View Article : Google Scholar
|
|
17
|
Kumar S, Nei M, Dudley J and Tamura K:
MEGA: a biologist-centric software for evolutionary analysis of DNA
and protein sequences. Brief Bioinform. 9:299–306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Petrocca F, Visone R, Onelli MR, et al:
E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest
and apoptosis in gastric cancer. Cancer Cell. 13:272–286. 2008.
|
|
20
|
Bloomston M, Frankel WL, Petrocca F, et
al: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu M, Wu H, Liu T, et al: Regulation of
the cell cycle gene, BTG2, by miR-21 in human laryngeal
carcinoma. Cell Res. 19:828–837. 2009. View Article : Google Scholar
|
|
23
|
Avissar M, Christensen BC, Kelsey KT and
Marsit CJ: MicroRNA expression ratio is predictive of head and neck
squamous cell carcinoma. Clin Cancer Res. 15:2850–2855. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang SS, Jiang WW, Smith I, et al:
MicroRNA alterations in head and neck squamous cell carcinoma. Int
J Cancer. 123:2791–2797. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tran N, McLean T, Zhang X, et al: MicroRNA
expression profiles in head and neck cancer cell lines. Biochem
Biophys Res Commun. 358:12–17. 2007. View Article : Google Scholar
|
|
26
|
Adams BD, Furneaux H and White BA: The
micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen
receptor-α (ERα) and represses ERα messenger RNA and protein
expression in breast cancer cell lines. Mol Endocrinol.
21:1132–1147. 2007.PubMed/NCBI
|
|
27
|
Anderson C, Catoe H and Werner R: MIR-206
regulates connexin43 expression during skeletal muscle development.
Nucleic Acids Res. 34:5863–5871. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Davis E, Caiment F, Tordoir X, et al:
RNAi-mediated allelic trans-interaction at the imprinted
Rtl1/Peg11 locus. Curr Biol. 15:743–749. 2005.PubMed/NCBI
|
|
29
|
Garzon R, Pichiorri F, Palumbo T, et al:
MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl
Acad Sci USA. 103:5078–5083. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Greco SJ and Rameshwar P: MicroRNAs
regulate synthesis of the neurotransmitter substance P in human
mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci
USA. 104:15484–15489. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krek A, Grün D, Poy MN, et al:
Combinatorial microRNA target predictions. Nat Genet. 37:495–500.
2005. View
Article : Google Scholar
|
|
32
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng F, Wehbe-Janek H, Henson R, Smith H
and Patel T: Epigenetic regulation of microRNA-370 by interleukin-6
in malignant human cholangiocytes. Oncogene. 27:378–386. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Poy MN, Eliasson L, Krutzfeldt J, et al: A
pancreatic islet-specific microRNA regulates insulin secretion.
Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rosenberg MI, Georges SA, Asawachaicharn
A, Analau E and Tapscott SJ: MyoD inhibits Fstl1 and Utrn
expression by inducing transcription of miR-206. J Cell Biol.
175:77–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang G, van der Walt JM, Mayhew G, et al:
Variation in the miRNA-433 binding site of FGF20 confers risk for
Parkinson disease by overexpression of α-synuclein. Am J Hum Genet.
82:283–289. 2008.PubMed/NCBI
|
|
38
|
Wong TS, Liu XB, Chung-Wai Ho A, et al:
Identification of pyruvate kinase type M2 as potential oncoprotein
in squamous cell carcinoma of tongue through microRNA profiling.
Int J Cancer. 123:251–257. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu L and Belasco JG: Micro-RNA regulation
of the mammalian lin-28 gene during neuronal differentiation
of embryonal carcinoma cells. Mol Cell Biol. 25:9198–9208.
2005.PubMed/NCBI
|
|
40
|
Ashburner M, Ball CA, Blake JA, et al:
Gene ontology: tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
